FFVM
AMTI

Founders Fund V Management’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Founders Fund V Management’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,611,615
Closed -$567K – 4
2023
Q3 		$567K Hold
3,611,615
– – 70.62% 1
2023
Q2 		$932K Hold
3,611,615
– – 80.24% 1
2023
Q1 		$1.16M Hold
3,611,615
– – 88.91% 1
2022
Q4 		$1.52M Hold
3,611,615
– – 88.39% 1
2022
Q3 		$3.5M Hold
3,611,615
– – 88.93% 1
2022
Q2 		$10.5M Hold
3,611,615
– – 84.9% 1
2022
Q1 		$27.2M Hold
3,611,615
– – 1.74% 3
2021
Q4 		$50.4M Hold
3,611,615
– – 2.67% 2
2021
Q3 		$93.4M Hold
3,611,615
– – 31.77% 3
2021
Q2 		$165M Hold
3,611,615
– – 56.39% 1
2021
Q1 		$159M Hold
3,611,615
– – 8.38% 4
2020
Q4 		$111M Buy
+3,611,615
New +$114M 28.36% 2

Other funds holding AMTI

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Founders Fund V Management's AMTI Position: Q4 2023 in Review

Founders Fund V Management sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q4 2023, closing a stake of 3,611,615 shares — an estimated $567K sold.

Founders Fund V Management first reported a position in AMTI in Q4 2020 and held it in 12 quarters. The position peaked at $165M in Q2 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • Founders Fund V Management reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Founders Fund V Management sold 3,611,615 Applied Molecular Transport Inc. Common Stock shares in Q4 2023, an estimated $567K.
  • Founders Fund V Management first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2020 and held it in 12 quarters.
  • Founders Fund V Management's Applied Molecular Transport Inc. Common Stock position peaked at $165M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q4 2023.

Based on Founders Fund V Management's 13F filing for Q4 2023, filed 14 Feb 2024.